Company news
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A (SSE:600329) news
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A news releases on 6ix. Latest, Jan 20, 2025: Announcement on the Implementation…
View Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A →
Press releases — page 2
Announcement on the Implementation of Repurchase and Cancellation of the A-share Restricted Stock Incentive Plan for 2019
January 19, 2025
Announcement on the Company Completing Transfer of 13% Equity of Tianjin TSKF Pharmaceutical Co., Ltd. and Related Party Transaction
December 31, 2024
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
December 30, 2024
Announcement on the Completion of Capital Increase for Jinyao Pacific Pharmaceutical Co., Ltd. and Related Party Transactions
December 26, 2024
Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2024
December 24, 2024
Announcement on Unlocking and Listing of Restricted Shares for the 3rd Restricted Stock Trading Period of the 2019 A-Share Restricted Stock Plan
December 20, 2024
Announcement on Resignation of General Manager
December 10, 2024
Announcement on Adding Extraordinary Proposal to the 3rd Extraordinary General Meeting in 2024
December 6, 2024
Announcement on Convening the Q3 2024 Performance Briefing
December 4, 2024
Announcement on Resignation and By-election of Supervisor
November 26, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
November 22, 2024
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2024
November 18, 2024
Notice on Convening the 3rd Extraordinary General Meeting in 2024
November 14, 2024
Announcement on the Achievements of Lifting Restriction Conditions in the 3rd Restricted Stock Trading Period of the 2019 A-Share Restricted Share Plan
November 11, 2024
Report for Q3 2024
October 30, 2024
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
October 29, 2024
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2024
October 23, 2024
Announcement on Signing the Revised and Restated "Joint Venture Contract" and "Articles of Association" with Shareholders of Joint-stock Company
September 27, 2024